Published on 19 Jul 2023 on Insider Monkey via Yahoo Finance

Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)

Laughing Water Capital, an investment management company, released its second-quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, investment in the fund returned 13.8%, net of all fees and expenses, compared to the SP500TR and the R2000 returns of 8.7% and 5.2%, respectively. The fund’s return so far in 2023 was 22.4% compared to benchmarks’ 16.9% and 8.1% returns, respectively. In addition, you can check the top 5 holdings of the fund to know its best picks in 2023.

Laughing Water Capital highlighted stocks like Enzo Biochem, Inc. (NYSE:ENZ) in the second quarter 2023 investor letter. Headquartered in Farmingdale, New York, Enzo Biochem, Inc. (NYSE:ENZ) is an integrated diagnostics, clinical lab, and life sciences company. On July 28, 2023, Enzo Biochem, Inc. (NYSE:ENZ) stock closed at $1.4900 per share. One-month return of Enzo Biochem, Inc. (NYSE:ENZ) was -20.32%, and its shares lost 38.43% of their value over the last 52 weeks. Enzo Biochem, Inc. (NYSE:ENZ) has a market capitalization of $74.095 million.

Laughing Water Capital made the following comment about Enzo Biochem, Inc. (NYSE:ENZ) in its second quarter 2023 investor letter: